Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis

Acta Neurologica Scandinavica

Volumn 95, Issue 5, 1997, Pages 280-283

  Martin, C ^a   Enbom, M ^b   Soderstrom M ^a   Fredrikson, S ^a   Dahl, H ^b   Lycke, J ^c   Bergstrom T ^c   Linde, A ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; Herpesvirus; HHV 6; Multiple sclerosis; Polymeiase chain reaction

Indexed keywords

ACICLOVIR; PLACEBO; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HERPES VIRUS; HUMAN; MALE; MULTIPLE SCLEROSIS; OPTIC NERVE DISEASE; POLYMERASE CHAIN REACTION; VIRUS DETECTION;

EID: 0030924266     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00210.x     Document Type: Article

References (38)

1. KURZKE JF. Epidemiological evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993: 6: 382-427.
2. RICE GPA. Virus-induced demyelination in man: models for multiple sclerosis. Curr Opin Neurol Neurosurg 1992: 5: 188-94.
3. JOHNSON RT. The virology of demyelinating disease. Ann Neurol 1994: 36 (Suppl.): S54-60.
4. MARTIN JR, HOLT RK, WEBSTER HDEF. Herpes-simplex-related antigen in human demyelinative disease and encephalitis. Acta Neuropathol 1988: 76: 325-37.
5. BERGSTRÖM T, ANDERSEN O, VAHLNE A. Isolation of herpes simplex virus type 1 during first attack of multiple sclerosis. Ann Neurol 1989: 26: 283-5.
6. HAAHR S, SOMMERLUND M, CHRISTENSEN T, JENSEN AW, HANSEN HJ, MOLLER-LARSEN A. A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease. Ann NY Acad Sci 1994: 724: 148-56.
7. ROSS RT, NICOLLE LE, CHEANG M. Varicella zoster virus and multiple sclerosis in a Hutterite population. J Clin Epidemiol 1995: 48: 1319-24.
8. LIEDTKE W, MALESSA R, FAUSTMANN PM, EIS-HÜBINGER A-M. Human herpesvirus 6 polymerase chain reaction in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995: 1: 253-8.
9. WILBORN F, SCHMIDT CA, BRINKMANN V, JENDROSKA K, OETTLE H, SIEGERT W. A potential role for human herpes" virus type 6 in nervous system disease. J Neuroimmunol 1994: 49: 213-14.
10. CHALLONER PB, SMITH KT, PARKER JD et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995: 92: 7440-4.
11. SOLA P, MERELLI E, MARASCA R et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993: 56: 917-19.
12. NORRBY E, LINK H, OLSSON J-E, PANELIUS M, SALMI A, VANDVIK B. Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun 1974: 10: 688.
13. SUMAYA CV, MYERS LW, ELLISON GW, ENCH Y. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 1985: 17: 371-7.
14. MATHIESEN T, VON HOLST H, FREDRIKSSON S et al. Total, anti-viral and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system. J Neurol 1989: 236: 238-42.
15. FELGENHAUER K, REIBER H. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes" virus induced diseases of the nervous system. Clin Invest 1992: 70: 28-37.
16. SCHUMACHER GA, BEEBE GW, KIBLER RF et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965: 122: 552-68.
17. KURTZKE JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983: 33: 1444-52.
18. LYCKE J, SVENNERHOLM B, HJELMQUIST E et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. J Neurol 1996: 243: 214-24.
19. PERKIN GD, ROSE FC. Optic neuritis and its differential diagnoses. 1979. Oxford University Press, Oxford.
20. SÖDERSTRÖM M. The clinical profile of optic neuritis: a prospective study. Ital J Neurol Sci 1995: 16: 167-76.
21. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 13: 227-31.
22. LINK H, TIBBLING G. Principles of albumin and IgG analyses in neurological disorder. II. Influence of serum concentrations on CSF and evaluation of blood-brain barrier damage. Scand J Clin Lab Invest 1977: 37: 391-6.
23. OLSSON T, KOSTULAS V, LINK H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double antibody peroxidase labelling and avidin-biotin amplification. Clin Chem 1984: 30: 1246-9.
24. AURELIUS E, JOHANSSON B, SKÖLDENBERG B, STALAND Å, FORSGREN M. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 1991: 337: 189-92.
25. AURELIUS E, JOHANSSON B, SKOLDENBERG B, FORSGREN M. Encephalitis in immunocompetent patients due to herpes simplex virus 1 or 2 as determined by PCR or type-specific antibody assays of cerebrospinal fluid. J Med Virol 1993: 39: 179-86.
26. CINQUE P, VAGO L, BRYTTING M et al. Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J Infect Dis 1992: 166: 1408-11.
27. CINQUE P, BRYTTING M, VAGO L et al. Epstein-Barr virus DNA in cerebrospinal fluid of patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993: 342: 398-401.
28. CINQUE P, VAGO L, DAHL H et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic disease of the central nervous system in HIV-infected patients. AIDS 1996: 10: 951-8.
29. WANG F-Z, DAHL H, LINDE A, BRYTTING M, EHRNST A, LJUNGMAN P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996: 88: 3615-20.
30. XU Y, ZHAORI G, VENE S et al. Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples. Pediatr Infect Dis J 1996: 15: 1018-24.
31. LANDGREN M, KYLLERMAN M, BERGSTRÖM T. DOTEVALL L, LJUNGSTRÖM L, RICKSTEN A. Diagnosis of Epstein-Barr virus-induced central nervous system infections by DNA amplifications from cerebrospinal fluid. Ann Neurol 1994: 35: 631-5.
32. STUDAHL M, RICKSTEN A, SANDBERG T, ELOWSSON S, HERNER S, BERGSTRÖM T. Cytomegalovirus infection in the central nervous system in noncompromised hosts. Acta Neurol Scand 1994: 89: 451-7.
33. BERGSTRÖM T. Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations. Scand J Infect Dis 1996: (Suppl 100): 41-5.
34. SALAHUDDIN SZ, ABLASHI DV, MARKHAM PD et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986: 234: 596-601.
35. YAMANISHI K, OKUNO T, SHIRAKI K et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988: 1: 1065-7.
36. CASERTA MT, BREESE HALL C, SCHNABLE K et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994: 170: 1586-9.
37. KNOX KK, CARRIGAN DR. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1995: 9: 69-73.
38. RIECKMANN P, ALBRECHT M, KIETZE B et al. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 1995: 37: 82-8.